Context Therapeutics' $100M placement; Blueprint raises guidance for rare disease drug
Plus, news about Novocure and Corvus:
Context Therapeutics’ $100M PIPE: Nextech led the private placement, and other investors like Ally Bridge …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
